This CME presents an expert interview on targeted therapy in FLT3-ITD–positive AML, focusing on clinical evidence for quizartinib and its application in clinical practice.... See more
This course explores personalised treatment in metastatic breast cancer, highlighting the role and clinical benefits of low-dose metronomic chemotherapy with oral agents.... See more